A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Clinical Investigation Training Program

Clinical Investigation Training Program
The Clinical Investigation Training Program (CITP) is committed to addressing the critical need for formal training and advancement in clinical research, as well as increasing the quantity, and more importantly, quality of well trained clinical investigators. The ultimate goal is to provide clinical research education, guided by apatient-centered philosophy, which will have a significant impact on cancer and other life-threatening diseases.
City of Hope's Clinical Investigation Training Program (CITP) is dedicated to a core group of objectives. Among these are:
  • Provide high-quality, multidisciplinary services to our scholars
  • Address the critical need for formal training and advancement in clinical investigation as well as increase the quantity and, more importantly, quality of well-trained clinical investigators.
  • Facilitate, through intensive mentoring, the transition fromscholar to independent clinical investigator
  • Bring City of Hope scientists and clinicians closer together to facilitate the bench-to-bedside continuum

CITP Core Curriculum

Core Curriculum
The City of Hope Clinical Investigation Training Program (CITP) is a yearlong (4 quarter) curriculum designed to present the principles and practices used in the planning and execution of patient-oriented research including principles and methods in biostatistics, clinical epidemiology, clinical trial development, ethics, and good clinical practices of research. Each course can be taken in any order throughout the year. A certificate in Clinical Research is awarded to scholars successfully completing the Program.
Methodology in Observational Studies CI510 (Fall) - Design & Analysis of Observational Research
Provides an overview of epidemiologic methods and their application to observational studies. Scholars will develop/enhance their ability to evaluate observational studies, including the adequacy of study design and the validity of stated conclusions. Scholars will also acquire the necessary conceptual frameworkto plan an observational study in collaboration with a statistical co-investigator.
Methodology in Therapeutic Studies CI520 (Winter) - Design& Analysis of Intervention Research
Provides anintroduction to the concepts, theory, and application of interventional clinical trials and the statistics commonly used to analyze these studies. This is a Biostatistics/Clinical Investiagation course that builds on basic background of biostatistics, and introductory clinical trials. This course will explore the fundamentals of clinical investigation including: the definition of study goals, application and theory, objectives and outcomes, trial design and outcome monitoring, and result reporting, as well as a brief review of the underlying statistical methods.
Study Design & Development CI530 (Spring) - Design & Development of Human Subject Research
Provides a review of the clinical study process as well as continued instruction in trial development. Scholars will experience the "Nuts and Bolts" of a clinical study, from submission, to committee review, activation, and monitoring. Each scholar will actively participate in the submission of a "mock" clinical protocol. The proper design, conduct, and analysis of a clinical study are imperative to the well being of each participant as well as the integrity of the study results. Responsible conduct of research and good clinical practice will be emphasized throughout the course as they are the cornerstones to an effective and efficient clinical study.
Scientific Writing & Evaluation CI550/1 (Summer)
This course will alternate yearly, and address topics in protocol writing and development (CI550) and career development awards (CI551). The emphasis of CI550 will be on developing a complete and feasible protocol leading to an efficient, effective clinical study. The classes will combine didactic instruction with small group discussions and "hands on" learning. The emphasis of CI551 will be on early career advancement, competitivegrant writing, and literature evaluation. This course will focus on developing a fundable, career development award suitable for peer review. Evaluations will be through oral presentations and a completed career development application.


Faculty and Mentors

The Clinical Investigation Training Program’s faculty members are nationally-renowned scholars and researchers who are experts in teaching and conducting research. Our multidisciplinary faculty members hail from the world’s most prestigious universities and research institutions, and are the recipients of numerous awards and accolades.  City of Hope’s intimate and collegial environment allows faculty members to be effective mentors to program participants, leading them down the path to professional clinical researcher.
Education and Training
As one of only a select few National Cancer Institute-designated Comprehensive Cancer Centers in the country, City of Hope integrates all aspects of cancer research, treatment and education. We offer a range of programs serving students, post-doctoral trainees, health and medical professionals.

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Local and national conferences, in-depth educational training and a certification program provide both current and aspiring health professionals opportunities to further their knowledge in their fields of interest.
City of Hope offers a range of programs and services, such as Graduate Medical Education & Clinical Training, that serve students, post-doctoral trainees, medical professionals and staff.
The goal of the Postdoctoral Training Office is to ensure the postdoctoral experience at City of Hope is rewarding and meaningful to all participants.
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. Bridget’s doctors told her she only had a year to live. Then she met neurosurgeon Dr. Behnam Badie. That was 5 years ago. The cancer grows...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • News about the risks or benefits of widespread cancer screening seem to arrive daily – 3D mammography for breast cancer, CT scans for lung cancer, PSA tests for prostate cancer and now pelvic exams for some women’s cancers. Missing in the headlines is a reflection of how cancer detection is evolving. Today’s ca...
  • Adults with sickle cell disease soon may have a new treatment option: bone marrow transplants. Children with sickle cell disease have been treated successfully with transplantation of bone marrow, more officially known as hematopoietic stem cells, from other people. But the procedure has been less successful in...
  • New pelvic exam recommendations or not, women shouldn’t give up those routine gynecological appointments. The revised guidelines from the American College of Physicians exempt most women from pelvic examinations, but a cancer specialist at City of Hope says women should still plan on regular visits with t...
  • Scientists have long searched for ways to bolster the immune system to fight diseases that seem to evade it, including cancer. Many have focused on monoclonal antibodies, trying to use them as trucks to drop off payloads of drugs right at the site of an infection or tumor. The problem, however, has been welding...
  • John Cloer was three months shy of his third birthday in 2004 when he was diagnosed with acute lymphoblastic leukemia. For the next three and a half years, he received chemotherapy at City of Hope, finally obtaining long-term remission. His parents Bill and Gina, along with John and his younger brother Steve, r...
  • Music makes a difference – in patient mood and in patient healing. To that end, patient care at City of Hope now has a special new program called the Musicians On Call Jason Pollack Bedside Performance Program, which brings live, in-room performances to patients undergoing treatment or unable to leave their hos...
  • Vaccinating people against hepatitis B could prevent diabetes from developing in some individuals, a new City of Hope study suggests. The study, an analysis of the National Health and Nutrition Examination Survey, indicated that people vaccinated for hepatitis B had a 50 percent reduction in risk for diabetes c...
  • Treatments for kidney cancer have improved dramatically in recent years, with new therapies already in use and others on the near horizon. The need has never been greater: Incidence rates for kidney cancer are rising. This year, nearly 64,000 new cases of kidney cancer will be diagnosed in the United States, an...
  • It is mid-afternoon on a Sunday at the cosmetics counter at Macy’s. A woman approaches with smiling eyes and dewy skin in a crisp white lab coat. I feel at ease as she offers me a seat. With a soft touch she applies eye makeup and powder to my forehead and chin. She is charming, […]
  • John Cloer became a teenager in May, an ordinary rite of passage made extraordinary because he is a cancer survivor – one of an estimated 370,000 pediatric cancer survivors in the U.S. He was three months shy of his third birthday in 2004 when what his parents Bill and Gina Cloer assumed was the flu was diagnos...